MCGLYNN MARGARET G bought NVAX
June 18, 2026 · Form 4 insider transaction
MCGLYNN MARGARET G bought 14,180 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,180
Price
$0.00
Total value
N/A
InsiderMCGLYNN MARGARET G
RoleDirector
CompanyNovavax, Inc. (NVAX)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after14,180
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.; One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.